or mycoplasma-induced rash and mucositis (MIRM), per the CDC. That doesn’t mean you will get those complications if you don’t treat walking pneumonia, though. “Untreated, the infection will ...
Ctexli also is the fourth FDA-approved drug in the portfolio of seven-year-old, Foster City-based Mirum (Nasdaq: MIRM), an enviable track record in a drug industry that can see companies devote ...